Cell therapy first for chronic heart failure
European Pharmaceutical Review
FEBRUARY 28, 2023
This study examined the effects of [MPCs] a specific type of stem cell obtained from the bone marrow of healthy adult donors,” the study’s lead author, Dr Emerson C Perin, PhD, FACC, Medical Director at The Texas Heart Institute shared with EPR.
Let's personalize your content